If you need more lookups,
subscriptions start at $34 USD/month.
James Raine Location
Basel, BS, CH
James Raine Work
Steering Committee Member @ (October 2022 - Present)
Director, Data Management TA Head Oncology @ (August 2022 - Present)
Associate Director, Data Management Leader @ (October 2020 - July 2022)
Associate Director, Data Management Leader @ (July 2017 - October 2020)
Project Data Scientist @ (December 2010 - July 2017)
Senior Data Manager @ (May 2010 - December 2010)
Clinical Data Manager @ (May 2009 - May 2010)
Clinical Data Associate 2 @ (July 2008 - March 2009)
Clinical Data Associate 1 @ (July 2007 - July 2008)
James Raine Education
Biozentrum, University of Basel
Diploma of Advanced Studies (Pharmaceutical Medicine)
2015-2017
University of Strathclyde
Bachelor of Science (BS) (Microbiology and Immunology)
2003-2007
Appleby Grammar School 1996-2003
James Raine Skills
Clinical Trial Management System Ctms
Clinical Trials
SAE Reconciliation
CRO
CDISC
Data Management
Medidata Rave Architect
Query Writing
Clinical Data Management
Good Clinical Practice Gcp
Life Sciences
Data Cleaning
Outlook
Reconciliation
Microsoft Word
Protocol
SOP development
Microsoft Excel
GCP
Deviations
Clinical Development
EDC
SAS programming
Cdash
Project Management
Line Management
Database Design
Pharmaceutical Industry
SDTM
Sop
Databases
Clinical Trial Management System
Good Clinical Practice
James Raine Summary
James Raine, based in Basel, BS, CH, is currently a Director, Data Management TA Head Oncology at Johnson & Johnson Innovative Medicine. James Raine brings experience from previous roles at ECLINICAL FORUM LIMITED, Johnson & Johnson Innovative Medicine and Actelion. James Raine holds a 2015 - 2017 Diploma of Advanced Studies in Pharmaceutical Medicine @ Biozentrum, University of Basel. With a robust skill set that includes Clinical Trial Management System Ctms, Clinical Trials, SAE Reconciliation, CRO, CDISC and more. James Raine has 2 emails on RocketReach.
Looking for a different James Raine?
Find contact details for 700 million professionals.